08/02/2019 (Agence Europe) – Stefan Oschmann, President of the European Federation of Pharmaceutical Industries and Associations (EFPIA), wrote a letter on Tuesday 5 February, in which he expressed deep concern about the European Parliament’s recent position on the revision of the Supplementary Protection Certificate (SPC) (see EUROPE 12178). For the President, “the compromise provisions proposed by the European Parliament diverge significantly from the limited scope of the initial...